Imagine waking up to the news that one of the most trusted pharmacy chains in Australia is teetering on the edge of collapse, leaving hundreds of jobs and millions of dollars in debt hanging in the balance. This is the stark reality for Priceline Pharmacy’s largest franchisee, Infinity Pharmacy Group, which now owes creditors a staggering $400 million. But here’s where it gets even more unsettling: despite being on the verge of a rescue deal, retail giant Wesfarmers abruptly pulled out, plunging the future of 54 stores into uncertainty.
By KYLIE STEVENS, SENIOR BREAKING NEWS REPORTER, AUSTRALIA (https://www.dailymail.co.uk/profile-1762/kylie-stevens.html)
Published: 23:47 GMT, 19 January 2026 | Updated: 00:24 GMT, 20 January 2026
The drama began in December when Wesfarmers placed Infinity Pharmacy Group into receivership, citing the franchisee’s inability to meet its financial obligations over an extended period. Richard Pearson, Wesfarmers Health’s chief customer officer, described the decision as 'unavoidable,' but this move has left many wondering: could this have been prevented? Pearson later confirmed to The Australian Financial Review that plans to recapitalize the struggling franchisee were officially off the table.
In a candid note to franchisees and staff, Pearson shed light on the deeper issue: 'Community pharmacies are pillars of trust in Australia, but Infinity’s aggressive, debt-driven expansion strategy threatened to erode that trust.' And this is the part most people miss: the collapse isn’t just about money—it’s about the fragile balance between growth and sustainability in an industry that millions rely on.
The financial fallout is staggering. Australian Pharmaceutical Industries is owed $110 million, while three of Australia’s Big Four banks are collectively out $145 million. Receivership firm KPMG and voluntary administrators Teneo are now tasked with selling Infinity’s 91-store network, a process that has already piqued the interest of rival pharmacy groups. But with 1,200 employees across nearly 100 stores, mostly in Queensland and NSW, the human cost of this collapse cannot be overlooked.
Here’s the controversial question: Did Infinity’s management bite off more than it could chew, or did external factors push it over the edge? And what does this mean for the future of community pharmacies in Australia? As the sale process unfolds, one thing is clear: this isn’t just a business story—it’s a cautionary tale about the risks of unchecked expansion. What’s your take? Share your thoughts in the comments below, and let’s spark a conversation about where we go from here. More updates to come.
